Universal-Beteiligungs- und Servicegesellschaft’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Buy
16,654
+3,808
+30% +$34.1K ﹤0.01% 2059
2026
Q1
$105K Buy
+12,846
New +$116K ﹤0.01% 2022
2025
Q4
Sell
-16,676
Closed -$145K 2142
2025
Q3
$145K Sell
16,676
-20,013
-55% -$156K ﹤0.01% 2038
2025
Q2
$231K Buy
36,689
+21,282
+138% +$141K ﹤0.01% 1899
2025
Q1
$98.8K Buy
+15,407
New +$127K ﹤0.01% 1946

Other funds holding NVAX

Universal-Beteiligungs- und Servicegesellschaft's NVAX Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Novavax (NVAX) stake by 30% in Q2 2026, buying an estimated $34.1K and bringing the position to 16,654 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NVAX in Q1 2025 and has held it in 5 quarters since. The position peaked at $231K in Q2 2025. 152 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 16,654 shares of Novavax worth $157K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 3,808 Novavax shares in Q2 2026, an estimated $34.1K.
  • Novavax made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2059 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Novavax in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Novavax position peaked at $231K in Q2 2025.
  • 152 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.